{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:31:10Z","timestamp":1790087470544,"version":"4.0.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:00:00Z","timestamp":1709337600000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.purol.2022.12.013","type":"journal-article","created":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T21:09:58Z","timestamp":1672780198000},"page":"145-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Envahissement ganglionnaire pelvien anatomopathologique apr\u00e8s cystectomie totale pour le traitement des tumeurs de vessie infiltrant le muscle\u00a0: une revue narrative de la litt\u00e9rature"],"prefix":"10.1016","volume":"33","author":[{"given":"P.-E.","family":"Gabriel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6135-1005","authenticated-orcid":false,"given":"U.","family":"Pinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Vaessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mozer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Chartier-Kastler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Roupr\u00eat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Seisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.purol.2022.12.013_bib0270","series-title":"Cancer today","year":"2020"},{"issue":"9","key":"10.1016\/j.purol.2022.12.013_bib0275","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrurol.2017.82","article-title":"Landmarks in the treatment of muscle-invasive bladder cancer","volume":"14","author":"Lobo","year":"2017","journal-title":"Nat Rev Urol"},{"issue":"15","key":"10.1016\/j.purol.2022.12.013_bib0280","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.purol.2022.07.145","article-title":"French AFU Cancer Committee Guidelines\u00a0\u2013\u00a0Update 2022-2024: muscle-invasive bladder cancer (MIBC)","volume":"32","author":"Neuzillet","year":"2022","journal-title":"Prog Urol"},{"issue":"16","key":"10.1016\/j.purol.2022.12.013_bib0285","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.3390\/cancers13164108","article-title":"Extranodal extension predicts poor survival outcomes among patients with bladder cancer","volume":"13","author":"Liao","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.purol.2022.12.013_bib0290","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1200\/JCO.2001.19.3.666","article-title":"Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients","volume":"19","author":"Stein","year":"2001","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.purol.2022.12.013_bib0295","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.purol.2018.06.002","article-title":"Impact de la chimioth\u00e9rapie n\u00e9oadjuvante sur la morbidit\u00e9 p\u00e9ri-op\u00e9ratoire de la cystectomie pour tumeur de vessie infiltrant le muscle","volume":"28","author":"Michel","year":"2018","journal-title":"Prog Urol"},{"issue":"6","key":"10.1016\/j.purol.2022.12.013_bib0300","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/annonc\/mdu126","volume":"25","author":"Kitamura","year":"2014","journal-title":"Ann Oncol"},{"issue":"18","key":"10.1016\/j.purol.2022.12.013_bib0305","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1200\/JCO.21.02051","article-title":"Dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin or gemcitabine and cisplatin as perioperative chemotherapy for patients with nonmetastatic muscle-invasive bladder cancer: results of the GETUG-AFU V05 VESPER Trial","volume":"40","author":"Pfister","year":"2022","journal-title":"J Clin Oncol"},{"issue":"34","key":"10.1016\/j.purol.2022.12.013_bib0310","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1200\/JCO.18.01148","article-title":"Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): an open-label, single-arm, Phase II study","volume":"36","author":"Necchi","year":"2018","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.purol.2022.12.013_bib0315","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/s41591-019-0628-7","article-title":"Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial","volume":"25","author":"Powles","year":"2019","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.purol.2022.12.013_bib0320","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.eururo.2009.10.026","article-title":"A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder","volume":"57","author":"Roth","year":"2010","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.purol.2022.12.013_bib0325","first-page":"106","article-title":"Changing practice of pelvic lymph node dissection in management of primary bladder cancer","volume":"68","author":"Crozier","year":"2016","journal-title":"Minerva Urol Nefrol"},{"key":"10.1016\/j.purol.2022.12.013_bib0330","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.suronc.2019.06.008","article-title":"Impact of lymph node dissection in radical cystectomy for bladder cancer: how many vs. how far?","volume":"30","author":"Choi","year":"2019","journal-title":"Surg Oncol"},{"issue":"2","key":"10.1016\/j.purol.2022.12.013_bib0335","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.eururo.2009.10.024","article-title":"Prospective randomized controlled trial of robotic versus open radical cystectomy for bladder cancer: perioperative and pathologic results","volume":"57","author":"Nix","year":"2010","journal-title":"Eur Urol"},{"issue":"11","key":"10.1016\/j.purol.2022.12.013_bib0340","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ejso.2014.03.008","article-title":"Robotic vs. open radical cystectomy in bladder cancer: a systematic review and meta-analysis","volume":"40","author":"Tang","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.purol.2022.12.013_bib0345","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/01.ju.0000032474.22093.06","article-title":"Superiority of ratio based lymph node staging for bladder cancer","volume":"169","author":"Herr","year":"2003","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.purol.2022.12.013_bib0350","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0022-5347(05)65284-6","article-title":"Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer","volume":"167","author":"Herr","year":"2002","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.purol.2022.12.013_bib0355","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/01.ju.0000052721.61645.a3","article-title":"Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base","volume":"169","author":"Konety","year":"2003","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.purol.2022.12.013_bib0360","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.eururo.2014.05.031","article-title":"The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review","volume":"66","author":"Bruins","year":"2014","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.purol.2022.12.013_bib0365","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.eururo.2018.09.047","article-title":"Extended versus limited lymph node dissection in bladder cancer patients undergoing radical cystectomy: survival results from a prospective, randomized trial","volume":"75","author":"Gschwend","year":"2019","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.purol.2022.12.013_bib0370","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/S0022-5347(05)65555-3","article-title":"Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens","volume":"166","author":"Bochner","year":"2001","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.purol.2022.12.013_bib0375","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.juro.2006.10.043","article-title":"Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer","volume":"177","author":"Stein","year":"2007","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.purol.2022.12.013_bib0380","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/his.13818","article-title":"Handling and reporting of pelvic lymphadenectomyspecimens in prostate and bladder cancer: a web-based survey by the European Network of Uropathology","volume":"74","author":"Prendeville","year":"2019","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.purol.2022.12.013_bib0385","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.eururo.2013.04.036","article-title":"Lymphadenectomy for bladder cancer at the time of radical cystectomy","volume":"64","author":"Tilki","year":"2013","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.purol.2022.12.013_bib0390","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.urolonc.2011.02.011","article-title":"Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder","volume":"31","author":"Kassouf","year":"2013","journal-title":"Urol Oncol"},{"issue":"4","key":"10.1016\/j.purol.2022.12.013_bib0395","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.eururo.2009.01.004","article-title":"The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer","volume":"55","author":"Karl","year":"2009","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.purol.2022.12.013_bib0400","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/bju.14242","article-title":"Poor prognosis of bladder cancer patients with occult lymph node metastases treated with neoadjuvant chemotherapy","volume":"122","author":"Cha","year":"2018","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.purol.2022.12.013_bib0405","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.urology.2008.07.035","article-title":"Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomy","volume":"73","author":"Kassouf","year":"2009","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.purol.2022.12.013_bib0410","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.eururo.2021.03.014","article-title":"Molecular characterization of residual bladder cancer after neoadjuvant pembrolizumab","volume":"80","author":"Necchi","year":"2021","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.purol.2022.12.013_bib0415","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0022-5347(01)61921-9","article-title":"Pelvic lymph node dissection can be curative in patients with node positive bladder cancer","volume":"161","author":"Vieweg","year":"1999","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.purol.2022.12.013_bib0420","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.ju.0000072422.69286.0e","article-title":"Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density","volume":"170","author":"Stein","year":"2003","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.purol.2022.12.013_bib0425","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00345-014-1319-0","article-title":"Cancer-specific mortality following radical cystectomy for bladder cancer with lymph node involvement: impact of pathologic disease features and adjuvant chemotherapy","volume":"33","author":"Clifton","year":"2015","journal-title":"World J Urol"},{"issue":"3","key":"10.1016\/j.purol.2022.12.013_bib0430","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2217\/fon.14.267","article-title":"Three-tiered nodal classification system for bladder cancer: a new proposal","volume":"11","author":"Pedrosa","year":"2015","journal-title":"Future Oncol"},{"issue":"11","key":"10.1016\/j.purol.2022.12.013_bib0435","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1002\/cncr.23474","article-title":"The association between extent oflymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy","volume":"112","author":"Wright","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.purol.2022.12.013_bib0440","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1186\/s12885-015-1448-x","article-title":"Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysis","volume":"15","author":"Ku","year":"2015","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.purol.2022.12.013_bib0445","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.eururo.2012.07.026","article-title":"Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis","volume":"64","author":"Fajkovic","year":"2013","journal-title":"Eur Urol"},{"issue":"11","key":"10.1016\/j.purol.2022.12.013_bib0450","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1245\/s10434-014-4359-1","article-title":"Extracapsular extension of pelvic lymph node metastasis is an independent prognostic factor in bladder cancer: a systematic review and meta-analysis","volume":"22","author":"Ahn","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.purol.2022.12.013_bib0455","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.suronc.2019.01.008","article-title":"The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy","volume":"28","author":"Marks","year":"2019","journal-title":"Surg Oncol"},{"issue":"1","key":"10.1016\/j.purol.2022.12.013_bib0460","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0022-5347(05)66067-3","article-title":"Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy","volume":"166","author":"Mills","year":"2001","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.purol.2022.12.013_bib0465","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.urology.2009.07.1259","article-title":"Aggregate lymph node metastasis diameter and survival after radical cystectomy for invasive bladder cancer","volume":"75","author":"Stephenson","year":"2010","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.purol.2022.12.013_bib0470","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1470-2045(14)71160-X","article-title":"Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial","volume":"16","author":"Sternberg","year":"2015","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.purol.2022.12.013_bib0475","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.eururo.2021.09.028","article-title":"Adjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and meta-analysis of individual participant data from randomised controlled trials","volume":"81","author":"Advanced Bladder Cancer (ABC) Meta-analysis Collaborators Group","year":"2022","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.purol.2022.12.013_bib0480","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jamaoncol.2017.2374","article-title":"Adjuvant chemotherapy vs. observation for patients with adverse pathologic features at radical cystectomy previously treated with neoadjuvant chemotherapy","volume":"4","author":"Seisen","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.purol.2022.12.013_bib0485","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1470-2045(21)00004-8","article-title":"Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial","volume":"22","author":"Bellmunt","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.purol.2022.12.013_bib0490","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa2034442","article-title":"Adjuvant nivolumab versus placebo in muscle-invasive urothelial carcinoma","volume":"384","author":"Bajorin","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.purol.2022.12.013_bib0495","doi-asserted-by":"crossref","first-page":"e0174978","DOI":"10.1371\/journal.pone.0174978","article-title":"Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer: a retrospective multicenter study","volume":"12","author":"Orr\u00e9","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.purol.2022.12.013_bib0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.euf.2021.11.004","article-title":"Adjuvant radiotherapy after radical cystectomy for patients with high-risk muscle-invasive bladder cancer: results of a multicentric phase II Trial","author":"Fonteyne","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.purol.2022.12.013_bib0505","doi-asserted-by":"crossref","first-page":"e174591","DOI":"10.1001\/jamasurg.2017.4591","article-title":"Adjuvant sandwich chemotherapy plus radiotherapy vs. adjuvant chemotherapy alone for locally advanced bladder cancer after radical cystectomy: a randomized phase 2 Trial","volume":"153","author":"Zaghloul","year":"2018","journal-title":"JAMA Surg"},{"key":"10.1016\/j.purol.2022.12.013_bib0510","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.purol.2019.09.008","article-title":"Usefulness of frozen section exams during radical cystectomy for urothelial carcinoma","volume":"30","author":"Cerf","year":"2020","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2022.12.013_bib0515","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0302-2838(02)00320-2","article-title":"After cystectomy, is it justified to perform a bladder replacement for patients with lymph node positive bladder cancer?","volume":"42","author":"Lebret","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2022.12.013_bib0520","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1464-410X.2011.10446.x","article-title":"Diffusion-weighted magnetic resonance imaging in patients selected for radical cystectomy: detection rate of pelvic lymph node metastases","volume":"109","author":"Papalia","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2022.12.013_bib0525","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1007\/s00330-018-5959-0","article-title":"Integrated analysis of 18F-FDG PET\/CT improves preoperative lymph node staging for patients with invasive bladder cancer","volume":"29","author":"Girard","year":"2019","journal-title":"Eur Radiol"},{"issue":"7","key":"10.1016\/j.purol.2022.12.013_bib0265","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1046\/j.1464-410x.2000.00614.x","article-title":"Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis","volume":"85","author":"Leissner","year":"2000","journal-title":"BJU Int"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708722005383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708722005383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:36:27Z","timestamp":1761114987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708722005383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1166708722005383"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2022.12.013","relation":{},"ISSN":["1166-7087"],"issn-type":[{"value":"1166-7087","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Envahissement ganglionnaire pelvien anatomopathologique apr\u00e8s cystectomie totale pour le traitement des tumeurs de vessie infiltrant le muscle\u00a0: une revue narrative de la litt\u00e9rature","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2022.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}